Predict your next investment

Venture Capital
biostar-capital.com

See what CB Insights has to offer

Investments

82

Portfolio Exits

12

Funds

5

About BioStar Capital

BioStar Capital is a value-add investor focused on transformational medical device technologies in cardiovascular and orthopaedic medicine. Combining the insight of experienced investment professionals and medical thought leaders, BioStar Capital identifies proprietary technologies that serve unmet patient needs and fit the acquisition criteria of leading medical device companies. BioStar Capital fills an important gap in medical device development and provides operational skills and clinical expertise in addition to capital, enabling the firm to actively mitigate risk, optimize product development, and secure successful exit.

BioStar Capital Headquarter Location

560 W. Mitchell Street #480

Petoskey, Michigan, 49770,

United States

231-487-9186

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing BioStar Capital

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find BioStar Capital in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Latest BioStar Capital News

Jeffrey Yau, PhD, VP of Data Science and Engineering at Walmart Global Technology, Joins BioStar Capital as Entrepreneur in Residence

May 26, 2021

Jeffrey Yau, PhD, VP of Data Science and Engineering at Walmart Global Technology, Joins BioStar Capital as Entrepreneur in Residence 0 PETOSKEY, Mich.–( BUSINESS WIRE )– BioStar Capital , a value-add investment firm focused on transformational medical device technologies that serve unmet patient and physician needs, today announced that Jeffrey Yau, PhD in Economics and VP of Data Science, Data Engineering, and Platform Engineering of Store Associate Tech at Walmart Global Technology, has joined the firm as an entrepreneur in residence (EIR). Dr. Yau was also previously Chief Data Scientist at AllianceBernstein, a global investment management and research firm with almost $700B in assets under management. As an EIR, Dr. Yau will expand BioStar’s expertise within the emerging field of data science and artificial intelligence (AI) in healthcare, as well as…

BioStar Capital Investments

82 Investments

BioStar Capital has made 82 investments. Their latest investment was in Calcium Solutions as part of their Seed VC on July 7, 2020.

CBI Logo

BioStar Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/7/2020

Seed VC

Calcium Solutions

$1.24M

Yes

1

6/22/2020

Series D

Foldax

$20M

No

Angel Physicians Fund, California Institute of Technology, Kairos Ventures, MemorialCare Innovation Fund, and Sayan Bioventures

7

6/3/2020

Unattributed VC - IV

NeuroClear Technologies

$10.75M

No

1

1/21/2020

Series B

Subscribe to see more

$99M

Subscribe to see more

10

11/5/2019

Unattributed VC - III

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/7/2020

6/22/2020

6/3/2020

1/21/2020

11/5/2019

Round

Seed VC

Series D

Unattributed VC - IV

Series B

Unattributed VC - III

Company

Calcium Solutions

Foldax

NeuroClear Technologies

Subscribe to see more

Subscribe to see more

Amount

$1.24M

$20M

$10.75M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Angel Physicians Fund, California Institute of Technology, Kairos Ventures, MemorialCare Innovation Fund, and Sayan Bioventures

Sources

1

7

1

10

10

BioStar Capital Portfolio Exits

12 Portfolio Exits

BioStar Capital has 12 portfolio exits. Their latest portfolio exit was TransMedics on May 02, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/2/2019

IPO

$991

2

9/21/2018

IPO

1

8/10/2016

Merger

1

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

5/2/2019

9/21/2018

8/10/2016

00/00/0000

00/00/0000

Exit

IPO

IPO

Merger

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Sources

2

1

1

10

10

BioStar Capital Fund History

5 Fund Histories

BioStar Capital has 5 funds, including BioStar Ventures III.

Closing Date

Fund

Fund Type

Status

Amount

Sources

9/16/2015

BioStar Ventures III

Early-Stage Venture Capital

$67.72M

3

9/30/2010

BioStar Ventures II LP

Subscribe to see more

$99M

10

2/1/2005

BioStar Private Equity Fund

Subscribe to see more

$99M

10

BSV III-XF ASI SPV

Subscribe to see more

$99M

10

BioStar Ventures III-XF

Subscribe to see more

$99M

10

Closing Date

9/16/2015

9/30/2010

2/1/2005

Fund

BioStar Ventures III

BioStar Ventures II LP

BioStar Private Equity Fund

BSV III-XF ASI SPV

BioStar Ventures III-XF

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Amount

$67.72M

$99M

$99M

$99M

$99M

Sources

3

10

10

10

10

BioStar Capital Team

8 Team Members

BioStar Capital has 8 team members, including current Chief Financial Officer, Paul A. Scott.

Name

Work History

Title

Status

Paul A. Scott

Chief Financial Officer

Current

Lisa Riedmiller

Controller

Current

Steven L. Almany

Managing Director

Current

Renee Masi

Managing Director

Current

Jeffrey F. O'Donnell

Managing Director

Current

Name

Paul A. Scott

Lisa Riedmiller

Steven L. Almany

Renee Masi

Jeffrey F. O'Donnell

Work History

Title

Chief Financial Officer

Controller

Managing Director

Managing Director

Managing Director

Status

Current

Current

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.